Drug intelligence / Profile preview

Hope Medicine kinase inhibitor (chemotherapy toxicity)

Development stage

Preclinical

Lead developer

Kurome Therapeutics

Modality

Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules

Administration

Oral, Intravenous, Intramuscular, Intravitreal, Suprachoroidal, Intrathecal